Contents

Search


epithelial cell adhesion molecule; Ep-CAM; tumor-associated Ca+2 signal transducer 1; major gastrointestinal tumor-associated protein GA733-2; epithelial cell surface antigen; epithelial glycoprotein; EGP; epithelial glycoprotein 314; EGP314; hEGP314; adenocarcinoma-associated antigen; KSA; KS 1/4 antigen; cell surface glycoprotein trop-1; CD326 (EPCAM, GA733-2, M1S2, M4S1, MIC18, TACSTD1, TROP1)

Function: - may act as a physical homophilic interaction molecule between intestinal epithelial cells (IECs) & intraepithelial lymphocytes (IELs) at the mucosal epithelium for providing immunological barrier as a first line of defense against mucosal infection Structure: - monomer - belongs to the EPCAM family - contains 1 thyroglobulin type-1 domain Compartment: - membrane; single-pass type 1 membrane protein Expression: - expressed in almost all epithelial cell membranes but not on mesodermal or neural cell membranes - found on the surface of adenocarcinomas Laboratory: - circulating tumor cell count identifies & quantifies EpCAM produced by epithelial tumor cells (carcinomas) [3] Pharmacology: - target of sacituzumab govitecan-hziy (Trodelvy), a drug FDA-approved for refractory triple-negative breast cancer

General

cluster-of-differentiation antigen; cluster designation antigen; CD antigen glycoprotein tumor (cancer or CA) antigen

Properties

SIZE: entity length = 314 aa MW = 35 kD COMPARTMENT: cellular membrane MOTIF: signal sequence {1-23} cysteine residue {C27} MODIFICATION: cysteine residue {C46} cysteine residue {C29} MODIFICATION: cysteine residue {C59} cysteine residue {C38} MODIFICATION: cysteine residue {C48} cysteine residue {C46} MODIFICATION: cysteine residue {C27} cysteine residue {C48} MODIFICATION: cysteine residue {C38} cysteine residue {C59} MODIFICATION: cysteine residue {C29} Thyroglobulin type-1 {63-135} MOTIF: cysteine residue {C66} MODIFICATION: cysteine residue {C99} N-glycosylation site {N74} cysteine residue {C99} MODIFICATION: cysteine residue {C66} cysteine residue {C110} MODIFICATION: cysteine residue {C116} N-glycosylation site {N111} cysteine residue {C116} MODIFICATION: cysteine residue {C110} cysteine residue {C118} MODIFICATION: cysteine residue {C135} cysteine residue {C135} MODIFICATION: cysteine residue {C118} N-glycosylation site {N198} transmembrane domain {266-288}

Database Correlations

OMIM 185535 UniProt P16422 Pfam PF00086 Entrez Gene 4072

References

  1. UniProt :accession P16422
  2. Atlas of Genetics & Cytogenetics in Oncology & Haematology http://atlasgeneticsoncology.org/genes/TACSTD1ID42459ch2p21.html
  3. ARUP Consult: Circulating Tumor Cell Count https://arupconsult.com/ati/circulating-tumor-cell-count